- Home
- / SpectraCure
SpectraCure
Stock Price
KR1.8
2024-10-29
Market Capitalization
KR172.7 M
2024-10-29
SpectraCure Summary
Company Summary
- Overview
- SpectraCure is a company that provides treatment of internal solid cancer tumors. It develops software with an interstitial photodynamic therapy system. The company also delivers photo-reactive drugs.
- Type
- Public
- Status
- Active
- Founded
- 2003
- Website
- https://spectracure.com
- Cybersecurity rating
Table of Contents
SpectraCure Financials
Summary Financials
- Gross profit (FY, 2025)
- (kr6.3M)
- Net income (FY, 2025)
- (kr56.1M)
- Cash (FY, 2025)
- kr13.5M
- EBIT (FY, 2025)
- (kr55.0M)
- Enterprise value
- $162.0M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026